Clinuvel compared to Imugene, page-56

It could ultimately be a winning play and Wolgen certainly is an intelligent guy. I've often felt like he's holding these cards close to his chest that one day he'll slap down and say "royal flush, we've cornered the melanocortin market and the next decade we'll call all the shots on a billion dollar plus market". You certainly need to maintain control to achieve that but it's just time is a factor and in recent years what I've seen are things like the adolescent patient approval being ballsed up and ridiculous claims about indications that can't be named for years. Or well respected directors running for the door well ahead of schedule. All whilst senior management are ridiculously well paid and they run glitzy soirees in Monaco whilst claiming buying back shares would send an overly opulent signal?!?! These things shouldn't be happening if we're being steered by a tight lipped genius just biding his time. Anyway enough negativity. Do Vitiligo right and we'll be sweet!